Cargando…
Activation of the Aryl Hydrocarbon Receptor in Endothelial Cells Impairs Ischemic Angiogenesis in Chronic Kidney Disease
RATIONALE: Chronic kidney disease (CKD) is a strong risk factor for peripheral artery disease (PAD) that is associated with worsened clinical outcomes. CKD leads to accumulation of tryptophan metabolites that associate with adverse limb events in PAD and are ligands of the aryl hydrocarbon receptor...
Autores principales: | Palzkill, Victoria R., Tan, Jianna, Yang, Qingping, Morcos, Juliana, Laitano, Orlando, Ryan, Terence E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401998/ https://www.ncbi.nlm.nih.gov/pubmed/37546909 http://dx.doi.org/10.1101/2023.07.24.550410 |
Ejemplares similares
-
Chronic aryl hydrocarbon receptor activity phenocopies smoking‐induced skeletal muscle impairment
por: Thome, Trace, et al.
Publicado: (2021) -
The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?
por: Mo, Yenan, et al.
Publicado: (2020) -
Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease
por: Curran, Colleen S., et al.
Publicado: (2022) -
Genetic dissection of endothelial transcriptional activity of zebrafish aryl hydrocarbon receptors (AHRs)
por: Sugden, Wade W., et al.
Publicado: (2017) -
Single-Nuclei RNA-Sequencing of the Gastrocnemius Muscle in Peripheral Artery Disease
por: Pass, Caroline G., et al.
Publicado: (2023)